Tag: Zydus Cadila
Zydus Cadila partners with CHEMI to launch Enoxaparin Sodium Injection in US
Zydus Pharmaceuticals Inc, USA, a fully-owned subsidiary of Cadila Healthcare (Zydus Cadila), has signed a license and supply deal with CHEMI SpA for launching the ... Read More
Zydus Cadila gets EUA for ZyCoV-D vaccine for Covid-19 in India
Zydus Cadila (Cadila Healthcare) said that it has secured the emergency use authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D vaccine ... Read More
Zydus Cadila gets FDA approval for Mesalamine Extended-Release Capsules
Zydus Cadila said that it has secured final approval from the US Food and Drug Administration (FDA) to market Mesalamine Extended-Release Capsules in the strength ... Read More
Zydus Cadila gets FDA nod for chemotherapy drug Pemetrexed generic
Cadila Healthcare (also known as Zydus Cadila) said that it has secured tentative approval from the US Food and Drug Administration (FDA) for marketing Pemetrexed ... Read More
Zydus Cadila secures tentative approval from FDA for Brivaracetam Tablets
Cadila Healthcare (also known as Zydus Cadila) said that it has secured tentative approval from the US Food and Drug Administration (FDA) to market Brivaracetam ... Read More
Zydus Cadila leverages technology to fight counterfeiting of drugs
Cadila Healthcare (also known as Zydus Cadila) said that it has adopted a new technology initiative called ‘Zydus Verify’ to protect patients against counterfeit drugs. ... Read More
Zydus Cadila gets FDA approval for Fluphenazine Hydrochloride Tablets
Cadila Healthcare (also known as Zydus Cadila) said that it has secured final approval from the US Food and Drug Administration (FDA) to market Fluphenazine ... Read More
Cadila Healthcare to bring Black Fungus drug AmphoTLC to India
Cadila Healthcare (also known as Zydus Cadila) has signed a license supply and commercialization agreement with Taiwanese pharma company TLC to commercialize the latter’s Black ... Read More
India clears Zydus Cadila’s Virafin for treatment of moderate Covid-19
Zydus Cadila has secured restricted emergency use approval for ‘Virafin’, Pegylated Interferon alpha-2b (PegIFN) from the Drug Controller General of India (DCGI) for the treatment ... Read More